The Impact of BCR-ABL1 Transcript Type on Tyrosine Kinase Inhibitor Responses and Outcomes in Patients With Chronic Myeloid Leukemia
Cancer - United States
doi 10.1002/cncr.31408
Full Text
Open PDFAbstract
Available in full text
Date
April 25, 2018
Authors
Publisher
Wiley